Using this combined analysis approach, we considered whether metabolic imaging of NAD(P)H could reveal the dynamic relationship between HER2 inhibition and altered metabolism in squamous cell carcinoma (SCC). This evidence concerns the gene ERBB2 and squamous cell carcinoma.